cbdMD, Inc.
YCBD
$0.68
-$0.0249-3.53%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.03M | 19.59M | 19.22M | 19.48M | 20.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.03M | 19.59M | 19.22M | 19.48M | 20.64M |
| Cost of Revenue | 7.38M | 7.38M | 7.38M | 7.49M | 7.55M |
| Gross Profit | 11.64M | 12.22M | 11.84M | 12.00M | 13.09M |
| SG&A Expenses | 11.91M | 11.99M | 12.35M | 13.29M | 14.60M |
| Depreciation & Amortization | 1.15M | 1.16M | 1.16M | 1.15M | 1.53M |
| Other Operating Expenses | 332.50K | 300.30K | 627.90K | 835.70K | 2.81M |
| Total Operating Expenses | 20.82M | 20.86M | 21.56M | 22.80M | 26.52M |
| Operating Income | -1.79M | -1.27M | -2.34M | -3.32M | -5.88M |
| Income Before Tax | -1.51M | -158.80K | -2.69M | -3.70M | -19.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.51 | -0.16 | -2.69 | -3.70 | -19.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.51M | -158.80K | -2.69M | -3.70M | -19.42M |
| EBIT | -1.79M | -1.27M | -2.34M | -3.32M | -5.88M |
| EBITDA | -641.50K | -111.30K | -1.17M | -2.17M | -4.35M |
| EPS Basic | -5.26 | -6.25 | -15.18 | -18.84 | -151.56 |
| Normalized Basic EPS | -0.80 | -1.26 | -3.52 | -5.24 | -19.27 |
| EPS Diluted | -5.27 | -6.26 | -15.19 | -18.86 | -151.60 |
| Normalized Diluted EPS | -0.80 | -1.26 | -3.52 | -5.24 | -19.27 |
| Average Basic Shares Outstanding | 7.95M | 2.62M | 2.21M | 2.01M | 1.32M |
| Average Diluted Shares Outstanding | 7.95M | 2.62M | 2.21M | 2.01M | 1.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -3.43% |